BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21656570)

  • 1. Trifluoperazine regulation of calmodulin binding to Fas: a computational study.
    Pan D; Yan Q; Chen Y; McDonald JM; Song Y
    Proteins; 2011 Aug; 79(8):2543-56. PubMed ID: 21656570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of calmodulin-Fas death domain interaction: an integrated experimental and computational study.
    Fancy RM; Wang L; Napier T; Lin J; Jing G; Lucius AL; McDonald JM; Zhou T; Song Y
    Biochemistry; 2014 Apr; 53(16):2680-8. PubMed ID: 24702583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calmodulin binding to the Fas-mediated death-inducing signaling complex in cholangiocarcinoma cells.
    Chen Y; Pawar P; Pan G; Ma L; Liu H; McDonald JM
    J Cell Biochem; 2008 Feb; 103(3):788-99. PubMed ID: 17654480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and biophysical characterization of the interactions between the death domain of Fas receptor and calmodulin.
    Fernandez TF; Samal AB; Bedwell GJ; Chen Y; Saad JS
    J Biol Chem; 2013 Jul; 288(30):21898-908. PubMed ID: 23760276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calmodulin Binding to Death Receptor 5-mediated Death-Inducing Signaling Complex in Breast Cancer Cells.
    Fancy RM; Kim H; Zhou T; Zinn KR; Buchsbaum DJ; Song Y
    J Cell Biochem; 2017 Aug; 118(8):2285-2294. PubMed ID: 28092099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric effects of the antipsychotic drug trifluoperazine on the energetics of calcium binding by calmodulin.
    Feldkamp MD; O'Donnell SE; Yu L; Shea MA
    Proteins; 2010 Aug; 78(10):2265-82. PubMed ID: 20544963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformation and free energy analyses of the complex of calcium-bound calmodulin and the Fas death domain.
    Suever JD; Chen Y; McDonald JM; Song Y
    Biophys J; 2008 Dec; 95(12):5913-21. PubMed ID: 18820240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calmodulin binding to cellular FLICE-like inhibitory protein modulates Fas-induced signalling.
    Pawar PS; Micoli KJ; Ding H; Cook WJ; Kappes JC; Chen Y; McDonald JM
    Biochem J; 2008 Jun; 412(3):459-68. PubMed ID: 18257744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADAM15 in Apoptosis Resistance of Synovial Fibroblasts: Converting Fas/CD95 Death Signals Into the Activation of Prosurvival Pathways by Calmodulin Recruitment.
    Janczi T; Böhm BB; Fehrl Y; DeGiacomo P; Kinne RW; Burkhardt H
    Arthritis Rheumatol; 2019 Jan; 71(1):63-72. PubMed ID: 30003689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of trifluoperazine with Tetrahymena calmodulin. A 19F NMR study.
    Shimizu T; Hatano M; Muto Y; Nozawa Y
    FEBS Lett; 1984 Jan; 166(2):373-7. PubMed ID: 6420195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the Calmodulin-Binding Domains of Fas Death Receptor.
    Chang BJ; Samal AB; Vlach J; Fernandez TF; Brooke D; Prevelige PE; Saad JS
    PLoS One; 2016; 11(1):e0146493. PubMed ID: 26735300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancer.
    Yuan K; Yong S; Xu F; Zhou T; McDonald JM; Chen Y
    Oncotarget; 2015 Sep; 6(28):25308-19. PubMed ID: 26320171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular dynamics simulation of the calmodulin-trifluoperazine complex in aqueous solution.
    Yamaotsu N; Suga M; Hirono S
    Biopolymers; 2001 Apr; 58(4):410-21. PubMed ID: 11180054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitor and peptide binding to calmodulin characterized by high pressure Fourier transform infrared spectroscopy and Förster resonance energy transfer.
    Cinar S; Czeslik C
    Biochim Biophys Acta Proteins Proteom; 2018; 1866(5-6):617-623. PubMed ID: 29555454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markov state modelling reveals heterogeneous drug-inhibition mechanism of Calmodulin.
    Westerlund AM; Sridhar A; Dahl L; Andersson A; Bodnar AY; Delemotte L
    PLoS Comput Biol; 2022 Oct; 18(10):e1010583. PubMed ID: 36206305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of trifluoperazine on calcium binding by calmodulin. A microcalorimetric study.
    Tanokura M; Yamada K
    J Biol Chem; 1985 Jul; 260(15):8680-2. PubMed ID: 4019446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calmodulin binding to the Fas death domain. Regulation by Fas activation.
    Ahn EY; Lim ST; Cook WJ; McDonald JM
    J Biol Chem; 2004 Feb; 279(7):5661-6. PubMed ID: 14594800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposing orientations of the anti-psychotic drug trifluoperazine selected by alternate conformations of M144 in calmodulin.
    Feldkamp MD; Gakhar L; Pandey N; Shea MA
    Proteins; 2015 May; 83(5):989-96. PubMed ID: 25694384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the Interactions between Calmodulin and Death Receptor 5 in Triple-negative and Estrogen Receptor-positive Breast Cancer Cells: AN INTEGRATED EXPERIMENTAL AND COMPUTATIONAL STUDY.
    Fancy RM; Wang L; Zeng Q; Wang H; Zhou T; Buchsbaum DJ; Song Y
    J Biol Chem; 2016 Jun; 291(24):12862-12870. PubMed ID: 27129269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of trifluoperazine with porcine calmodulin 19F NMR and induced CD spectral studies.
    Shimizu T; Hatano M
    FEBS Lett; 1983 Aug; 160(1-2):182-6. PubMed ID: 6411490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.